These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9178651)

  • 21. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig.
    Roberts C; Hatcher P; Hagan JJ; Austin NE; Jeffrey P; Wyman P; Gaster LM; Routledge C; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):177-83. PubMed ID: 10961381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2003 May; 167(2):153-8. PubMed ID: 12644890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.
    Malagié I; Trillat AC; Bourin M; Jacquot C; Hen R; Gardier AM
    J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
    Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and role of serotonin 5-HT1A and 5-HT1B receptors in primary cultures of rat embryonic rostral raphe nucleus neurons.
    Héry F; Boulenguez P; Sémont A; Héry M; Becquet D; Faudon M; Deprez P; Fache MP
    J Neurochem; 1999 May; 72(5):1791-801. PubMed ID: 10217255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig.
    Roberts C; Price GW; Gaster L; Jones BJ; Middlemiss DN; Routledge C
    Neuropharmacology; 1997; 36(4-5):549-57. PubMed ID: 9225280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SB-236057-A: a selective 5-HT1B receptor inverse agonist.
    Roberts C; Watson J; Price GW; Middlemiss DN
    CNS Drug Rev; 2001; 7(4):433-44. PubMed ID: 11830759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.
    Thomas DR; Soffin EM; Roberts C; Kew JN; de la Flor RM; Dawson LA; Fry VA; Coggon SA; Faedo S; Hayes PD; Corbett DF; Davies CH; Hagan JJ
    Neuropharmacology; 2006 Sep; 51(3):566-77. PubMed ID: 16846620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
    Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT autoreceptors in the regulation of 5-HT release from guinea pig raphe nucleus and hypothalamus.
    Moret C; Briley M
    Neuropharmacology; 1997; 36(11-12):1713-23. PubMed ID: 9517443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):89-94. PubMed ID: 12595948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.